BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Inflammatory disorder
,
Retina
,
Amniocentesis
,
Cisplatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pituitary tumor- transforming proteins
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Expression of pituitary tumor transforming gene in human renal clear cell carcinoma and its signific…
Clinical significance of pituitary tumor transforming gene 1 and transgelin-2 in pancreatic cancer.
Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenti…
Rol of pituitary tumour-transforming gene (PTTG) in the pituitary adenomas].
A single mutation in Securin induces chromosomal instability and enhances cell invasion.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors
The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Dea…
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ